A SNP in CX3C chemokine receptor 1 (CXCR31, fractalkine receptor) is associated with reduced survival in sporadic ALS subjects; however, this SNP fails to associate with ALS risk (60). The gene discussed is CX3CR1; the disease is amyotrophic lateral sclerosis.